Rapport Therapeutics, Inc. Quarterly Liabilities and Equity in USD from Q4 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Rapport Therapeutics, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2023 to Q2 2025.
  • Rapport Therapeutics, Inc. Liabilities and Equity for the quarter ending June 30, 2025 was $285M, a 17.5% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $285M -$60.6M -17.5% Jun 30, 2025 10-Q 2025-08-07
Q1 2025 $302M Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $315M +$160M +103% Dec 31, 2024 10-Q 2025-08-07
Q3 2024 $331M Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $346M Jun 30, 2024 10-Q 2024-08-08
Q4 2023 $155M Dec 31, 2023 10-K 2025-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.